| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ... Annals of the rheumatic diseases 69 (10), 1809-1815, 2010 | 1486 | 2010 |
| Behçet's syndrome Y Yazici, I Simsek, H Yazici Inflammatory Diseases of Blood Vessels, 289-298, 2012 | 238 | 2012 |
| Immunopathogenesis of Behçet’s disease with special emphasize on the possible role of antigen presenting cells S Pay, İ Şimşek, H Erdem, A Dinç Rheumatology international 27, 417-424, 2007 | 182 | 2007 |
| A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis Ankara Rheumatology Study Group, S Pay, N Türkçapar, M Kalyoncu, ... Clinical rheumatology 25, 639-644, 2006 | 153 | 2006 |
| Optic neuritis occurring with anti-tumour necrosis factor α therapy I Simsek, H Erdem, S Pay, G Sobaci, A Dinc Annals of the rheumatic diseases 66 (9), 1255-1258, 2007 | 142 | 2007 |
| Serum interleukin-18 levels in patients with Behçet’s disease. Is its expression associated with disease activity or clinical presentations? U Musabak, S Pay, H Erdem, I Simsek, A Pekel, A Dinc, A Sengul Rheumatology international 26, 545-550, 2006 | 109 | 2006 |
| Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet’s disease. Does interleukin-1β play a major role in Behçet’s … S Pay, H Erdem, A Pekel, I Simsek, U Musabak, A Sengul, A Dinc Rheumatology International 26, 608-613, 2006 | 92 | 2006 |
| The close association between dental and periodontal treatments and oral ulcer course in behcet’s disease: a prospective clinical study U Karacayli, G Mumcu, I Simsek, S Pay, O Kose, H Erdem, H Direskeneli, ... Journal of oral pathology & medicine 38 (5), 410-415, 2009 | 81 | 2009 |
| Lorecivivint, a novel Intraarticular CDC‐like kinase 2 and dual‐specificity tyrosine phosphorylation‐regulated kinase 1A inhibitor and Wnt pathway modulator for the treatment … Y Yazici, TE McAlindon, A Gibofsky, NE Lane, D Clauw, M Jones, ... Arthritis & Rheumatology 72 (10), 1694-1706, 2020 | 79 | 2020 |
| Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever I Simsek, S Pay, A Pekel, A Dinc, U Musabak, H Erdem, A Sengul Rheumatology international 27, 807-811, 2007 | 67 | 2007 |
| Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis E Bozoglu, A Dinc, H Erdem, S Pay, I Simsek, IH Kocar Clinical and Experimental Rheumatology 23 (4), S, 2005 | 61 | 2005 |
| Delayed diagnosis of tuberculous arthritis H Erdem, O Baylan, I Simsek, A Dinc, S Pay, M Kocaoglu Japanese journal of infectious diseases 58 (6), 373-375, 2005 | 60 | 2005 |
| Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? S Pay, T Abbasov, H Erdem, U Musabak, I Simsek, A Pekel, A Akdogan, ... Clinical and Experimental Rheumatology 25 (4), S70, 2007 | 59 | 2007 |
| Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever S Yilmaz, M Cinar, I Simsek, H Erdem, S Pay Rheumatology 54 (3), 564-565, 2015 | 58 | 2015 |
| A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis Y Yazici, TE McAlindon, A Gibofsky, NE Lane, C Lattermann, N Skrepnik, ... Osteoarthritis and cartilage 29 (5), 654-666, 2021 | 57 | 2021 |
| Patient-driven assessment of disease activity in Behçet’s syndrome: cross-cultural adaptation, reliability and validity of the Turkish version of the Behçet’s Syndrome Activity … S Yilmaz, I Simsek, M Cinar, H Erdem, O Kose, Y Yazici, S Pay Clin Exp Rheumatol 31 (3 Suppl 77), 77-83, 2013 | 54 | 2013 |
| Color removal from denim production facility wastewater by electrochemical treatment process and optimization with regression method Ö Kahraman, İ Şimşek Journal of cleaner production 267, 122168, 2020 | 43 | 2020 |
| TNF inhibitors: new and old agents for rheumatoid arthritis I Simsek Bulletin of the NYU hospital for joint diseases 68 (3), 204-204, 2010 | 42 | 2010 |
| Penetration of meropenem and cefepim into pancreatic tissue during the course of experimental acute pancreatitis U Saglamkaya, MR Mas, M Yasar, I Simsek, NN Mas, F Kocabalkan Pancreas 24 (3), 264-268, 2002 | 41 | 2002 |
| Inhibition of inducible nitric oxide synthase reduces bacterial translocation in a rat model of acute pancreatitis I Simsek, M Refik, M Yasar, M Ozyurt, U Saglamkaya, S Deveci, B Comert, ... Pancreas 23 (3), 296-301, 2001 | 41 | 2001 |
